1. Home
  2. EYPT vs ESOA Comparison

EYPT vs ESOA Comparison

Compare EYPT & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$0.43

Market Cap

273.3M

Sector

Industrials

ML Signal

HOLD

Logo Energy Services of America Corporation

ESOA

Energy Services of America Corporation

HOLD

Current Price

$9.48

Market Cap

239.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
ESOA
Founded
1987
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Water Sewer Pipeline Comm & Power Line Construction
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
273.3M
239.4M
IPO Year
2005
2006

Fundamental Metrics

Financial Performance
Metric
EYPT
ESOA
Price
$0.43
$9.48
Analyst Decision
Buy
Strong Buy
Analyst Count
13
3
Target Price
★ $25.91
$25.00
AVG Volume (30 Days)
★ 2.6M
79.9K
Earning Date
11-04-2026
12-08-2026
Dividend Yield
N/A
★ 1.74%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.35
Revenue
$7,539,000.00
★ $122,465,826.00
Revenue This Year
N/A
$15.34
Revenue Next Year
$967.16
$6.65
P/E Ratio
★ N/A
$26.31
Revenue Growth
N/A
★ 2.74
52 Week Low
$2.93
$7.84
52 Week High
$19.11
$19.94

Technical Indicators

Market Signals
Indicator
EYPT
ESOA
Relative Strength Index (RSI) 15.08 27.37
Support Level N/A $8.62
Resistance Level $3.57 $9.61
Average True Range (ATR) 0.20 0.37
MACD -0.04 -0.10
Stochastic Oscillator 0.67 14.86

Price Performance

Historical Comparison
EYPT
ESOA

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

Share on Social Networks: